Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

Sign up for GitHub

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Jump to bottom

Terms not added to MAxO #49

Open
LCCarmody opened this issue Sep 24, 2019 · 0 comments
Open

Terms not added to MAxO #49

LCCarmody opened this issue Sep 24, 2019 · 0 comments

Comments

@LCCarmody
Copy link

ALPHA-GLUCOSIDASE INHIBITORS      
T-TYPE CALCIUM-CHANNEL BLOCKER      
SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE (L-type calcium channel blocker      
Erectile dysfunction drugs Unsure, this would fall under PDE5 inhibitors or some category?    
K-CHANNEL BLOCKERS      
Weight loss drugs      
antiarrythmic classes 1A, 1B, 1C, and 3.  

at the moment we are only adding Sulfonylurea Antidiabetic Agent and not distinguishing 1st and 2nd generation sulfonylureas.
@matentzn
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Assignees
No one assigned
Labels
None yet
Projects
None yet
Milestone
No milestone
Development

No branches or pull requests
1 participant
@LCCarmody